Anti-CHD8 monoclonal antibody

Pre-made anti-CHD8 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CHD8/CHD8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2428-Ab-1/ GM-Tg-hg-IP2428-Ab-2Anti-Human CHD8 monoclonal antibodyHuman
GM-Tg-rg-IP2428-Ab-1/ GM-Tg-rg-IP2428-Ab-2Anti-Rat CHD8 monoclonal antibodyRat
GM-Tg-mg-IP2428-Ab-1/ GM-Tg-mg-IP2428-Ab-2Anti-Mouse CHD8 monoclonal antibodyMouse
GM-Tg-cynog-IP2428-Ab-1/ GM-Tg-cynog-IP2428-Ab-2Anti-Cynomolgus/ Rhesus macaque CHD8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2428-Ab-1/ GM-Tg-felg-IP2428-Ab-2Anti-Feline CHD8 monoclonal antibodyFeline
GM-Tg-cang-IP2428-Ab-1/ GM-Tg-cang-IP2428-Ab-2Anti-Canine CHD8 monoclonal antibodyCanine
GM-Tg-bovg-IP2428-Ab-1/ GM-Tg-bovg-IP2428-Ab-2Anti-Bovine CHD8 monoclonal antibodyBovine
GM-Tg-equg-IP2428-Ab-1/ GM-Tg-equg-IP2428-Ab-2Anti-Equine CHD8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2428-Ab-1/ GM-Tg-hg-IP2428-Ab-2; GM-Tg-rg-IP2428-Ab-1/ GM-Tg-rg-IP2428-Ab-2;
GM-Tg-mg-IP2428-Ab-1/ GM-Tg-mg-IP2428-Ab-2; GM-Tg-cynog-IP2428-Ab-1/ GM-Tg-cynog-IP2428-Ab-2;
GM-Tg-felg-IP2428-Ab-1/ GM-Tg-felg-IP2428-Ab-2; GM-Tg-cang-IP2428-Ab-1/ GM-Tg-cang-IP2428-Ab-2;
GM-Tg-bovg-IP2428-Ab-1/ GM-Tg-bovg-IP2428-Ab-2; GM-Tg-equg-IP2428-Ab-1/ GM-Tg-equg-IP2428-Ab-2
Products NameAnti-CHD8 monoclonal antibody
Formatmab
Target NameCHD8
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CHD8 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2428-Ag-1Recombinant multi-species CHD8/ AUTS18/ HELSNF1 protein


    Target information

    Target IDGM-IP2428
    Target NameCHD8
    Gene ID57680,67772,65027,708169,475401,101097402,507111,100059337
    Gene Symbol and Synonyms5830451P18Rik,AUTS18,Chd-8,CHD8,Duplin,HELSNF1,IDDAM,mKIAA1564
    Uniprot AccessionQ9HCK8,Q9JIX5
    Uniprot Entry NameCHD8_HUMAN,CHD8_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000100888
    Target ClassificationN/A

    The target: CHD8, gene name: CHD8, also named as AUTS18, HELSNF1. This gene encodes a member of the chromodomain-helicase-DNA binding protein family, which is characterized by a SNF2-like domain and two chromatin organization modifier domains. The encoded protein also contains brahma and kismet domains, which are common to the subfamily of chromodomain-helicase-DNA binding proteins to which this protein belongs. This gene has been shown to function in several processes that include transcriptional regulation, epigenetic remodeling, promotion of cell proliferation, and regulation of RNA synthesis. Allelic variants of this gene are associated with autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.